1
|
Yuan T, Merai D, Gunsch MJ, Peters R, Lohani S, Bernardoni F, Zompa MA, Ahmad IH, Regalado EL, Pohl CA. Universal ion chromatography method for anions in active pharmaceutical ingredients enabled by computer-assisted separation modeling. J Pharm Biomed Anal 2024; 241:115923. [PMID: 38244392 DOI: 10.1016/j.jpba.2023.115923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2023] [Revised: 10/22/2023] [Accepted: 12/12/2023] [Indexed: 01/22/2024]
Abstract
Ion Chromatography (IC) is one of the most widely used methods for analyzing ionic species in pharmaceutical samples. A universal IC method that can separate a wide range of different analytes is highly desired as it can save a lot of time for method development and validation processes. Herein we report the development of a universal method for anions in active pharmaceutical ingredients (APIs) using computer-assisted chromatography modeling tools. We have screened three different IC columns (Dionex IonPac AS28-Fast 4 µm, AS19 4 µm and AS11-HC 4 µm) to determine the best suitable column for universal IC method development. A universal IC method was then developed using an AS11-HC 4 µm column to separate 31 most common anionic substances in 36 mins. This method was optimized using LC Simulator and a model which precisely predicts the retention behavior of 31 anions was established. This model demonstrated an excellent match between predicted and experimental analyte retention time (R2 =0.999). To validate this universal IC method, we have studied the stability of sulfite and sulfide analytes in ambient conditions. The method was then validated for a subset of 29 anions using water and organic solvent/water binary solvents as diluents for commercial APIs. This universal IC method provides an efficient and simple way to separate and analyze common anions in APIs. In addition, the method development process combined with LC simulator modeling can be effectively used as a starting point during method development for other ions beyond those investigated in this study.
Collapse
Affiliation(s)
- Tianyu Yuan
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA.
| | - Dolee Merai
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Matthew J Gunsch
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Ryan Peters
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Sachin Lohani
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Frank Bernardoni
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Michael A Zompa
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Imad Haidar Ahmad
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Erik L Regalado
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | | |
Collapse
|
2
|
Chen Y, Jo J, Hernandez E, Wang H, Bernardoni F. Biocatalytic cascade process of islatravir: Analytical and regulatory control strategy of minor enantiomer. J Pharm Biomed Anal 2023; 234:115536. [PMID: 37343454 DOI: 10.1016/j.jpba.2023.115536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 05/16/2023] [Accepted: 06/15/2023] [Indexed: 06/23/2023]
Abstract
Commercial process of islatravir (MK-8591, EFdA) utilizes biocatalytic cascade reactions to construct the ribose moiety of the molecule which bears three chiral centers. However, this biocatalytic process also brought analytical challenges where all stereoisomers and process related compounds are controlled in one isolated intermediate, the final drug substance. A chiral LC method was developed to resolve all those compounds from islatravir and its minor enantiomer by thorough column screening and careful optimization. Detail of designing key method validation components such as method linearity, precision and robustness is discussed, and their results were presented. The method was successfully validated to fulfill various expectation from each individual health authority including FDA, EMA, PMDA, and ANVISA.
Collapse
Affiliation(s)
- Yun Chen
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA.
| | - Junyong Jo
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA.
| | - Edgar Hernandez
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Heather Wang
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| | - Frank Bernardoni
- Analytical Research and Development, MRL, Merck & Co., Inc., Rahway, NJ 07065, USA
| |
Collapse
|
3
|
Gunsch MJ, Schwalm EL, Ouimet CM, Halsey HM, Hamilton SE, Bernardoni F, Jo J. Development and validation of ion-pairing HPLC-CAD chromatography for measurement of Islatravir’s phosphorylated intermediates. J Pharm Biomed Anal 2022; 213:114684. [DOI: 10.1016/j.jpba.2022.114684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Revised: 02/17/2022] [Accepted: 02/18/2022] [Indexed: 11/30/2022]
|
4
|
Fier PS, Xu Y, Poirier M, Brito G, Zheng M, Bade R, Sirota E, Stone K, Tan L, Humphrey GR, Chang D, Bothe J, Zhang Y, Bernardoni F, Castro S, Zompa MA, Taylor J, Sirk KM, Diaz-Santana A, Diribe I, Emerson KM, Krishnamurthi B, Zhao R, Ward M, Xiao C, Ouyand H, Zhan J, Morris WJ. Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19. Org Process Res Dev 2021; 25:2806-2815. [PMID: 35095257 PMCID: PMC8790826 DOI: 10.1021/acs.oprd.1c00400] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2021] [Indexed: 11/29/2022]
Abstract
Herein is described the development of a large-scale manufacturing process for molnupiravir, an orally dosed antiviral that was recently demonstrated to be efficacious for the treatment of patients with COVID-19. The yield, robustness, and efficiency of each of the five steps were improved, ultimately culminating in a 1.6-fold improvement in overall yield and a dramatic increase in the overall throughput compared to the baseline process.
Collapse
Affiliation(s)
- Patrick S. Fier
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Yingju Xu
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Marc Poirier
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Gilmar Brito
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Michelle Zheng
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Rachel Bade
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Eric Sirota
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Kevin Stone
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Lushi Tan
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Guy R. Humphrey
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Darryl Chang
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Jameson Bothe
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Yongqian Zhang
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Frank Bernardoni
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Steve Castro
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Michael A. Zompa
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Jerry Taylor
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Kevin M. Sirk
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Anthony Diaz-Santana
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Ike Diribe
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Khateeta M. Emerson
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Bharath Krishnamurthi
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Ralph Zhao
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Michael Ward
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| | - Chengqian Xiao
- WuXi
AppTec Co., Ltd., WaiGaoQiao
Free Trade Zone, Shanghai 200131, China
| | - Honggui Ouyand
- WuXi
AppTec Co., Ltd., WaiGaoQiao
Free Trade Zone, Shanghai 200131, China
| | - Jianfeng Zhan
- WuXi
AppTec Co., Ltd., WaiGaoQiao
Free Trade Zone, Shanghai 200131, China
| | - William J. Morris
- Department
of Process Research and Development, Merck
& Co., Inc., Rahway, New Jersey 07065, United States
| |
Collapse
|
5
|
Boehm I, King JA, Bernardoni F, Geisler D, Seidel M, Ritschel F, Goschke T, Haynes JD, Roessner V, Ehrlich S. Subliminal and supraliminal processing of reward-related stimuli in anorexia nervosa. Psychol Med 2018; 48:790-800. [PMID: 28832300 DOI: 10.1017/s0033291717002161] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND Previous studies have highlighted the role of the brain reward and cognitive control systems in the etiology of anorexia nervosa (AN). In an attempt to disentangle the relative contribution of these systems to the disorder, we used functional magnetic resonance imaging (fMRI) to investigate hemodynamic responses to reward-related stimuli presented both subliminally and supraliminally in acutely underweight AN patients and age-matched healthy controls (HC). METHODS fMRI data were collected from a total of 35 AN patients and 35 HC, while they passively viewed subliminally and supraliminally presented streams of food, positive social, and neutral stimuli. Activation patterns of the group × stimulation condition × stimulus type interaction were interrogated to investigate potential group differences in processing different stimulus types under the two stimulation conditions. Moreover, changes in functional connectivity were investigated using generalized psychophysiological interaction analysis. RESULTS AN patients showed a generally increased response to supraliminally presented stimuli in the inferior frontal junction (IFJ), but no alterations within the reward system. Increased activation during supraliminal stimulation with food stimuli was observed in the AN group in visual regions including superior occipital gyrus and the fusiform gyrus/parahippocampal gyrus. No group difference was found with respect to the subliminal stimulation condition and functional connectivity. CONCLUSION Increased IFJ activation in AN during supraliminal stimulation may indicate hyperactive cognitive control, which resonates with clinical presentation of excessive self-control in AN patients. Increased activation to food stimuli in visual regions may be interpreted in light of an attentional food bias in AN.
Collapse
Affiliation(s)
- I Boehm
- Division of Psychological and Social Medicine and Developmental Neurosciences,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| | - J A King
- Division of Psychological and Social Medicine and Developmental Neurosciences,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| | - F Bernardoni
- Division of Psychological and Social Medicine and Developmental Neurosciences,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| | - D Geisler
- Division of Psychological and Social Medicine and Developmental Neurosciences,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| | - M Seidel
- Division of Psychological and Social Medicine and Developmental Neurosciences,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| | - F Ritschel
- Division of Psychological and Social Medicine and Developmental Neurosciences,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| | - T Goschke
- Department of Psychology,Technische Universität Dresden,Dresden,Germany
| | - J-D Haynes
- Bernstein Center for Computational Neuroscience, Charité Universitäts-Medizin,Berlin,Germany
| | - V Roessner
- Department of Child and Adolescent Psychiatry,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| | - S Ehrlich
- Division of Psychological and Social Medicine and Developmental Neurosciences,University Hospital Carl Gustav Carus, Technische Universität Dresden,Dresden,Germany
| |
Collapse
|
6
|
Pirrone GF, Mathew RM, Makarov AA, Bernardoni F, Klapars A, Hartman R, Limanto J, Regalado EL. Supercritical fluid chromatography-photodiode array detection-electrospray ionization mass spectrometry as a framework for impurity fate mapping in the development and manufacture of drug substances. J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1080:42-49. [DOI: 10.1016/j.jchromb.2018.02.006] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Revised: 02/04/2018] [Accepted: 02/06/2018] [Indexed: 10/18/2022]
|
7
|
Mattrey FT, Makarov AA, Regalado EL, Bernardoni F, Figus M, Hicks MB, Zheng J, Wang L, Schafer W, Antonucci V, Hamilton SE, Zawatzky K, Welch CJ. Current challenges and future prospects in chromatographic method development for pharmaceutical research. Trends Analyt Chem 2017. [DOI: 10.1016/j.trac.2017.07.021] [Citation(s) in RCA: 60] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
8
|
Barhate CL, Joyce LA, Makarov AA, Zawatzky K, Bernardoni F, Schafer WA, Armstrong DW, Welch CJ, Regalado EL. Ultrafast chiral separations for high throughput enantiopurity analysis. Chem Commun (Camb) 2017; 53:509-512. [DOI: 10.1039/c6cc08512a] [Citation(s) in RCA: 103] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Ultrafast chiral chromatography enables high throughput enantiopurity analysis (over one thousand samples in an 8 h workday) for enantioselective synthesis investigations.
Collapse
Affiliation(s)
| | - Leo A. Joyce
- Process Research & Development
- MRL
- Merck & Co., Inc
- Rahway
- USA
| | | | | | | | - Wes A. Schafer
- Process Research & Development
- MRL
- Merck & Co., Inc
- Rahway
- USA
| | | | | | | |
Collapse
|
9
|
Abstract
Methyl-terminated poly(dimethylsiloxanes) (PDMSs) are typically considered to be inert and not suitable for surface functionalization reactions because of the absence of readily hydrolyzable groups. Nevertheless, these siloxanes do react with silica and other oxides, producing chemically grafted organic surfaces. Known since the 1970s and then forgotten and recently rediscovered, this reaction provides a versatile yet simple method for the covalent functionalization of inorganic surfaces. In this work, we have explored the reactions of linear methyl-terminated and cyclic PDMS and bis-fluoroalkyl disiloxanes for the surface functionalization of mesoporous silica (Dpore ≈ 30-35 nm). The optimal reaction conditions included 24 h of contact of neat siloxane liquids and silica at 120-250 °C (depending on the siloxane). A study of the reactions of silicas with different extents of hydration demonstrated the critical role of water in facilitating the grafting of the siloxanes. The proposed reaction mechanism involved the hydrolysis of the adsorbed siloxanes by the Lewis acidic centers (presumably formed by water adsorbed onto surface defects) followed by the coupling of silanols to the surface to produce grafted siloxanes. For rigorously dehydrated silicas (calcination ∼1000 °C), an alternative pathway that did not require water and involved the reaction of the siloxanes with the strained siloxane rings was also plausible. According to FTIR and chemical analysis, the reactions of bis-fluoroalkyl disiloxanes and cyclic PDMS (D3-D5) produced covalently-attached monolayer surfaces, and the reactions of high-MM methyl-terminated PDMS produced polymeric grafted silicas with a PDMS mass content of up to 50%. As evidenced by the high contact angles of ∼130°/100° (adv/rec) and the negligible amount of water adsorption over the entire range of relative pressures, including saturation (p/p0 → 1), the siloxane-grafted porous silicas show uniform, high-quality hydrophobic surfaces. An overall comparison of siloxanes with classical silane coupling agents (i.e., silanes with readily hydrolyzable functionalities such as chloro, amino, etc.) demonstrated that the reactions of siloxanes produced surfaces of similar quality and, although requiring higher temperatures, used noncorrosive, less hazardous reagents, thereby providing an environmentally benign alternative to the chemical functionalization of metal oxide surfaces.
Collapse
Affiliation(s)
- Gabriel Graffius
- Department of Chemistry and Biochemistry, Seton Hall University , South Orange, New Jersey 07079, United States
| | | | | |
Collapse
|
10
|
Roshchina TM, Shonija NK, Bernardoni F, Fadeev AY. Combined nitrogen, hexane, and benzene adsorption characterization of pores and surfaces of lyophobic mesoporous silicas. Langmuir 2014; 30:9355-9360. [PMID: 25040549 DOI: 10.1021/la500660s] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
For lyophobic porous surfaces, structural analysis by vapor adsorption is complicated due to weak adsorbate-adsorbent interactions and limited wetting of the pores (nonzero contact angles). To investigate further, adsorption isotherms of three distinct adsorbates (nitrogen - 77 K, n-hexane and benzene - 298 K) were studied for SBA-15 ordered mesoporous silica where the surface was functionalized with lyophobic perfluoroalkyl groups (C6F13 termini). The results demonstrated a clear advantage of the combined use of the adsorption isotherms of less surface sensitive (nitrogen) and more surface sensitive (hydrocarbons) adsorbates. The adsorption of nitrogen provided basic structural characteristics like surface area, pore volume, and pore size distribution, while the isotherms of benzene and n-hexane were used to characterize wetting (contact angles) and surface energy of the C6F13 surfaces within the pores. For the first time, the statistical film thickness for nitrogen, benzene, and n-hexane are being reported for the adsorption on fluorinated surfaces, thereby providing critical data for the pore size and the contact angle determination of the lyophobic materials.
Collapse
Affiliation(s)
- T M Roshchina
- Department of Chemistry, M.V. Lomonosov Moscow State University , Moscow 119991, Russian Federation
| | | | | | | |
Collapse
|
11
|
Marques R, Bernardoni F, Pollack S, Helmy R. Development of an automated system for preparation of liquid scintillation counting samples for radiolabeled pharmaceuticals. J Labelled Comp Radiopharm 2013; 57:121-4. [DOI: 10.1002/jlcr.3156] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2013] [Revised: 09/26/2013] [Accepted: 10/28/2013] [Indexed: 11/11/2022]
Affiliation(s)
- Rosemary Marques
- Merck Research Laboratories; Merck and Co., Inc.; Rahway NJ 07065 USA
| | - Frank Bernardoni
- Merck Research Laboratories; Merck and Co., Inc.; Rahway NJ 07065 USA
| | - Scott Pollack
- Merck Research Laboratories; Merck and Co., Inc.; Rahway NJ 07065 USA
| | - Roy Helmy
- Merck Research Laboratories; Merck and Co., Inc.; Rahway NJ 07065 USA
| |
Collapse
|
12
|
Roshchina TM, Shoniya NK, Tayakina OY, Tkachenko OP, Kustov LM, Bernardoni F, Fadeev AY. Role of the concentration and nature of grafted groups in the adsorption of hydrocarbon vapors on silica modified by monofunctional polyfluoroalkylsilanes. Russ J Phys Chem 2012. [DOI: 10.1134/s0036024412030260] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
13
|
Bernardoni F, Fadeev AY. Adsorption and wetting characterization of hydrophobic SBA-15 silicas. J Colloid Interface Sci 2011; 356:690-8. [DOI: 10.1016/j.jcis.2011.01.033] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2010] [Revised: 01/07/2011] [Accepted: 01/11/2011] [Indexed: 11/28/2022]
|
14
|
Bernardoni F, Sajonz P, Zang J, Lee C, Marcinko S, Abrahim A, Helmy R. Looking Beyond the Column: An Investigation into Method Irreproducibility for an Active Pharmaceutical Ingredient. Chromatographia 2009. [DOI: 10.1365/s10337-009-1381-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
15
|
Welch CJ, Hyun MH, Kubota T, Schafer W, Bernardoni F, Choi HJ, Wu N, Gong X, Lipshutz B. Microscale HPLC enables a new paradigm for commercialization of complex chiral stationary phases. Chirality 2008; 20:815-9. [PMID: 18293368 DOI: 10.1002/chir.20548] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The small column size (0.3 mm i.d. x 15 cm) used in microscale HPLC contains only a small fraction (<1%) of the chromatographic packing material of a typical analytical HPLC column. Consequently, chromatographic stationary phases that are prohibitively expensive in conventional HPLC, owing either to synthetic complexity or costly starting materials, may become commercially viable in the microscale format. To illustrate this point, a previously described, synthetically complex, crown ether chiral stationary phase was prepared and evaluated in the microscale format, showing excellent separation of the enantiomers of underivatized amine analytes.
Collapse
Affiliation(s)
- Christopher J Welch
- Separation and Purification Center of Excellence, Merck & Co, Inc., Rahway, New Jersey 07065, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Welch CJ, Sajonz P, Spencer G, Leonard W, Henderson D, Schafer W, Bernardoni F. Microscale HPLC Predicts Preparative Performance at Millionfold Scale. Org Process Res Dev 2008. [DOI: 10.1021/op800107u] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Christopher J. Welch
- Separation Center of Excellence, Process Research, Merck & Co., Inc. Rahway, New Jersey 07065, U.S.A
| | - Peter Sajonz
- Separation Center of Excellence, Process Research, Merck & Co., Inc. Rahway, New Jersey 07065, U.S.A
| | - Glenn Spencer
- Separation Center of Excellence, Process Research, Merck & Co., Inc. Rahway, New Jersey 07065, U.S.A
| | - William Leonard
- Separation Center of Excellence, Process Research, Merck & Co., Inc. Rahway, New Jersey 07065, U.S.A
| | - Derek Henderson
- Separation Center of Excellence, Process Research, Merck & Co., Inc. Rahway, New Jersey 07065, U.S.A
| | - Wes Schafer
- Separation Center of Excellence, Process Research, Merck & Co., Inc. Rahway, New Jersey 07065, U.S.A
| | - Frank Bernardoni
- Separation Center of Excellence, Process Research, Merck & Co., Inc. Rahway, New Jersey 07065, U.S.A
| |
Collapse
|
17
|
Mandò M, Margiacchi GP, Alioto R, Ferri L, Bernardoni F, Alberti G, Teti A, Simone LD, Bardelli M. [Introduction of definite molecular weight heparan sulfate in a protocol of prevention of deep venous thrombosis in prosthetic orthopedic surgery]. Minerva Cardioangiol 1996; 44:457-60. [PMID: 8999370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Use of definite molecular weight heparan sulphate in a protocol for the prevention of deep venous thrombosis in the total joint replacement surgery. The authors propose a working protocol for the prevention of deep venous thrombosis in prosthetic orthopaedic surgery. It requires that integration of pharmacological, anaesthesiological, rheological and physiokinesitherapic measures, it has permitted a very good prevention of thromboembolic disease and it is well-tolerated and safe. The protocol requires: peripheral anaesthesia (sub-arachnoidal block), pre and post-operative pharmacological treatment with heparan-sulphate of a fixed molecular weight, haemodilution with maintenance of the haematocrit at no more than 30%, early physiokinesitherapy associated with the use of elastic stockings graduated tension. The fifty patients treated with this protocol were controlled during the pre-operative and post-operative stage and one month later and no thrombo-embolic complications resulted.
Collapse
Affiliation(s)
- M Mandò
- UO Anestesia e Rianimazione, USL 8-Zona Valdarno Montevarchi (Arezzo)
| | | | | | | | | | | | | | | | | |
Collapse
|